Tazeen Ahmad
Stock Analyst at Bank of America Securities
(4.30)
# 1,352
Out of 4,596 analysts
1007
Total ratings
57.1%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $410 → $346 | $205.52 | +68.35% | 49 | Jul 30, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $199 → $214 | $166.80 | +28.30% | 48 | Jul 30, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $856 → $891 | $762.63 | +16.83% | 13 | Jul 30, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $95 → $96 | $68.01 | +41.16% | 51 | Jul 30, 2026 | |
| INCY Incyte | Reiterated: Buy | $136 → $140 | $119.52 | +17.14% | 55 | Jul 28, 2026 | |
| PHVS Pharvaris | Reiterated: Hold | $33 → $35 | $32.62 | +7.30% | 19 | Jul 28, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | n/a | $24.91 | - | 48 | Jul 27, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,088 → $1,103 | $853.82 | +29.17% | 65 | Jul 27, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $30 | $25.87 | +15.96% | 47 | Jul 15, 2026 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Buy | $15 | $8.98 | +67.04% | 36 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 | $14.86 | +27.86% | 70 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $99.25 | - | 43 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $23.02 | +34.67% | 21 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $288 → $306 | $243.91 | +25.46% | 71 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $307 → $312 | $385.16 | -18.99% | 5 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $162 | $130.21 | +24.41% | 10 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $598 → $600 | $477.10 | +25.76% | 25 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $33.98 | +32.43% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $748.00 | - | 7 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $125 | $103.40 | +20.89% | 16 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $8.17 | +230.48% | 20 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $10 | $5.86 | +70.65% | 6 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $8.32 | +224.52% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $158.61 | +26.10% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $131 | $134.09 | -2.30% | 6 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $3 | $3.58 | -16.20% | 23 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.10 | - | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $90.58 | +38.00% | 53 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $2.2 | $2.45 | -10.20% | 12 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $24.17 | - | 13 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $1.76 | +70.45% | 21 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $27.07 | +21.91% | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $4 | $6.60 | -39.39% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $8.12 | -1.48% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $47.30 | +22.63% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.10 | +57.02% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $8.03 | +74.35% | 22 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.61 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $79 | $10.18 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $1 | $1.05 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $0.5 | $15.62 | n/a | 7 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.65 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $4.60 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $307.83 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $22.21 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $9 | $16.86 | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $8 | $0.7559 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $54.82 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $23.39 | n/a | 1 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $1.51 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $13.50 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $48 | $26.41 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $4.83 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $9.11 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $1.17 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $7.19 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $114.49 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $20.97 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $49.15 | n/a | 1 | Sep 19, 2014 |
Alnylam Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $410 → $346
Current: $205.52
Upside: +68.35%
Neurocrine Biosciences
Jul 30, 2026
Reiterated: Buy
Price Target: $199 → $214
Current: $166.80
Upside: +28.30%
Regeneron Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $856 → $891
Current: $762.63
Upside: +16.83%
PTC Therapeutics
Jul 30, 2026
Reiterated: Buy
Price Target: $95 → $96
Current: $68.01
Upside: +41.16%
Incyte
Jul 28, 2026
Reiterated: Buy
Price Target: $136 → $140
Current: $119.52
Upside: +17.14%
Pharvaris
Jul 28, 2026
Reiterated: Hold
Price Target: $33 → $35
Current: $32.62
Upside: +7.30%
Ultragenyx Pharmaceutical
Jul 27, 2026
Maintained: Buy
Price Target: n/a
Current: $24.91
Upside: -
argenx SE
Jul 27, 2026
Reiterated: Buy
Price Target: $1,088 → $1,103
Current: $853.82
Upside: +29.17%
ACADIA Pharmaceuticals
Jul 15, 2026
Reiterated: Buy
Price Target: $30
Current: $25.87
Upside: +15.96%
BioCryst Pharmaceuticals
Jul 15, 2026
Reiterated: Buy
Price Target: $15
Current: $8.98
Upside: +67.04%
Jul 15, 2026
Reiterated: Sell
Price Target: $19
Current: $14.86
Upside: +27.86%
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $99.25
Upside: -
Jul 15, 2026
Reiterated: Buy
Price Target: $31
Current: $23.02
Upside: +34.67%
Jul 14, 2026
Reiterated: Buy
Price Target: $288 → $306
Current: $243.91
Upside: +25.46%
Jul 13, 2026
Reiterated: Sell
Price Target: $307 → $312
Current: $385.16
Upside: -18.99%
Jul 13, 2026
Reiterated: Buy
Price Target: $162
Current: $130.21
Upside: +24.41%
Jul 13, 2026
Reiterated: Buy
Price Target: $598 → $600
Current: $477.10
Upside: +25.76%
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $33.98
Upside: +32.43%
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $748.00
Upside: -
Jun 30, 2026
Reiterated: Buy
Price Target: $110 → $125
Current: $103.40
Upside: +20.89%
Jun 22, 2026
Reiterated: Buy
Price Target: $27
Current: $8.17
Upside: +230.48%
Jun 22, 2026
Reiterated: Buy
Price Target: $9 → $10
Current: $5.86
Upside: +70.65%
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $8.32
Upside: +224.52%
Jun 15, 2026
Maintained: Buy
Price Target: $200
Current: $158.61
Upside: +26.10%
Jun 11, 2026
Maintained: Buy
Price Target: $131
Current: $134.09
Upside: -2.30%
Jun 2, 2026
Maintained: Sell
Price Target: $8 → $3
Current: $3.58
Upside: -16.20%
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $27.10
Upside: -
Jun 1, 2026
Maintained: Buy
Price Target: $125
Current: $90.58
Upside: +38.00%
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $2.45
Upside: -10.20%
May 21, 2026
Reiterated: Sell
Price Target: n/a
Current: $24.17
Upside: -
May 21, 2026
Reiterated: Sell
Price Target: $3
Current: $1.76
Upside: +70.45%
May 21, 2026
Reiterated: Buy
Price Target: $35 → $33
Current: $27.07
Upside: +21.91%
May 15, 2026
Downgraded: Sell
Price Target: $18 → $4
Current: $6.60
Upside: -39.39%
May 8, 2026
Reiterated: Sell
Price Target: $8
Current: $8.12
Upside: -1.48%
May 8, 2026
Reiterated: Buy
Price Target: $58
Current: $47.30
Upside: +22.63%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $5.10
Upside: +57.02%
Mar 18, 2026
Reiterated: Hold
Price Target: $14
Current: $8.03
Upside: +74.35%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $1.61
Upside: n/a
Sep 19, 2024
Maintained: Buy
Price Target: $82 → $79
Current: $10.18
Upside: n/a
Oct 17, 2023
Maintained: Sell
Price Target: $2 → $1
Current: $1.05
Upside: n/a
Aug 11, 2023
Downgraded: Sell
Price Target: $7 → $0.5
Current: $15.62
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $2.65
Upside: n/a
Mar 27, 2023
Maintained: Sell
Price Target: $6
Current: $4.60
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $307.83
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $22.21
Upside: n/a
Apr 19, 2022
Maintained: Sell
Price Target: $10 → $9
Current: $16.86
Upside: n/a
Jul 21, 2021
Maintained: Buy
Price Target: $16 → $8
Current: $0.7559
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $54.82
Upside: n/a
Jun 3, 2019
Initiated Coverage: Hold
Price Target: $28
Current: $23.39
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $1.51
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $13.50
Upside: n/a
Oct 10, 2018
Maintained: Hold
Price Target: $46 → $48
Current: $26.41
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $4.83
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $9.11
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $1.17
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $7.19
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $114.49
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $20.97
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $49.15
Upside: n/a